Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Federica Rapetti

Showing results (1-10 of 12) with videos related to

Pageof 2
Sort By:
Molecules (Basel, Switzerland)|August 6, 2020
Pyrazolyl-Ureas as Interesting Scaffold in Medicinal ChemistryChiara Brullo, Federica Rapetti, Olga Bruno
International Journal of Molecular Sciences|August 10, 2024
PDE4D: A Multipurpose Pharmacological TargetMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|October 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and TumorigenesisMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|October 13, 2021
New Series of Pyrazoles and Imidazo-Pyrazoles Targeting Different Cancer and Inflammation PathwaysMaria Grazia Signorello, Federica Rapetti, Elda Meta, et al.
Chemmedchem|June 27, 2023
Insights into the Pharmacological Activity of the Imidazo-Pyrazole ScaffoldAndrea Spallarossa, Federica Rapetti, Maria Grazia Signorello, et al.
Bioorganic Chemistry|July 20, 2021
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomicsElva Morretta, Raffaella Belvedere, Antonello Petrella, et al.
Molecules (Basel, Switzerland)|February 23, 2020
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological TargetsChiara Brullo, Matteo Massa, Federica Rapetti, et al.
Chemmedchem|April 2, 2020
Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule SystemsChiara Brullo, Federica Rapetti, Silvana Alfei, et al.
Chemmedchem|February 22, 2023
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant AgentsElena Cichero, Federica Rapetti, Matteo Lusardi, et al.
European Journal of Medicinal Chemistry|June 25, 2021
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitorsChiara Brullo, Federica Rapetti, Sara Abbate, et al.
Pageof 2

Showing results (1-10 of 12) with videos related to

Sort By:
Pageof 2
Molecules (Basel, Switzerland)|August 6, 2020
Pyrazolyl-Ureas as Interesting Scaffold in Medicinal ChemistryChiara Brullo, Federica Rapetti, Olga Bruno
International Journal of Molecular Sciences|August 10, 2024
PDE4D: A Multipurpose Pharmacological TargetMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|October 29, 2025
USP7 at the Crossroads of Ubiquitin Signaling, Cell Cycle, and TumorigenesisMatteo Lusardi, Federica Rapetti, Andrea Spallarossa, et al.
Molecules (Basel, Switzerland)|October 13, 2021
New Series of Pyrazoles and Imidazo-Pyrazoles Targeting Different Cancer and Inflammation PathwaysMaria Grazia Signorello, Federica Rapetti, Elda Meta, et al.
Chemmedchem|June 27, 2023
Insights into the Pharmacological Activity of the Imidazo-Pyrazole ScaffoldAndrea Spallarossa, Federica Rapetti, Maria Grazia Signorello, et al.
Bioorganic Chemistry|July 20, 2021
Novel insights on the molecular mechanism of action of the anti-angiogenic pyrazolyl-urea GeGe-3 by functional proteomicsElva Morretta, Raffaella Belvedere, Antonello Petrella, et al.
Molecules (Basel, Switzerland)|February 23, 2020
New Hybrid Pyrazole and Imidazopyrazole Antinflammatory Agents Able to Reduce ROS Production in Different Biological TargetsChiara Brullo, Matteo Massa, Federica Rapetti, et al.
Chemmedchem|April 2, 2020
Discovery of New Antiproliferative Imidazopyrazole Acylhydrazones Able To Interact with Microtubule SystemsChiara Brullo, Federica Rapetti, Silvana Alfei, et al.
Chemmedchem|February 22, 2023
Scouting Different Phosphodiesterase 4 Inhibitor Chemotypes in Silico To Guide the Design of Anti-inflammatory/Antioxidant AgentsElena Cichero, Federica Rapetti, Matteo Lusardi, et al.
European Journal of Medicinal Chemistry|June 25, 2021
Design, synthesis, biological evaluation and structural characterization of novel GEBR library PDE4D inhibitorsChiara Brullo, Federica Rapetti, Sara Abbate, et al.
Pageof 2